[1]
Strimpakos, A.S. et al. 2012. Novel Agents in Early Phase Clinical Studies on Refractory Pancreatic Cancer. JOP. Journal of the Pancreas. 13, 2 (Mar. 2012), 166–168. DOI:https://doi.org/10.6092/1590-8577/714.